Indapamide
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1529 publications
In brief: Widaplik - another three-drug combination for hypertension.
Journal: The Medical letter on drugs and therapeutics
Published: June 15, 2026
Drug-drug interactions with Mexidol in patients with ischemic stroke: Analysis of data from randomized clinical trials
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: April 15, 2026
An analogue of indapamide: crystal structure and Hirshfeld surface analysis of 3-chloro-4-(N,N-diethynylsulfamo-yl)-N-(2-meth-yl-indolin-1-yl)benzamide.
Journal: Acta crystallographica. Section E, Crystallographic communications
Published: April 03, 2026
2024 Thai guidelines on the treatment of hypertension.
Journal: Asian biomedicine : research, reviews and news
Published: February 23, 2026
Widaplik: A Fixed-Dose Triple Combination for Initial Hypertension Therapy.
Journal: Cardiology in review
Published: January 28, 2026
Congenital methaemoglobinaemia, an incidental finding and a diagnostic confounder.
Journal: BMJ case reports
Published: January 22, 2026
Cyclodextrin-based inclusion complexes to enhance the solubility and oral bioavailability of indapamide: experimental and computational approaches.
Journal: Drug development and industrial pharmacy
Published: December 09, 2025
Stereoselective HPLC separation and configurational stability study of the N-nitrosamine impurity of indapamide.
Journal: Journal of chromatography. A
Published: November 25, 2025
Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study.
Journal: Diabetes, obesity & metabolism
Published: November 20, 2025
The First Russian Fixed Combination of Indapamide Retard and Candesartan: Results of Two Pharmacokinetic and Bioequivalence Studies.
Journal: Kardiologiia
Published: November 13, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension.
Journal: Open heart
Published: November 12, 2025
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.
Journal: Drug design, development and therapy
Published: November 09, 2025
Last Updated: 06/30/2026